Entrada Therapeutics Inc (TRDA) is a Healthcare · Biotechnology company listed on NASDAQ. Price $6.75 (-2.17%), Market cap $0.24B, 52-week low–high $5.02 ~ $16.03.
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates are based on a novel therapeutic; a robust development portfolio of genetic medicines for the potential treatment of neuromuscular and inherited retinal diseases. Its preclinical product includes ENTR-601-44; ENTR-601-45; and VX-670. The company was formerly known as CycloPorters, Inc., and changed its name to Entrada Therapeutics, Inc., in October 2017. Entrada Therapeutics, Inc. was incorporated
Financial statements, price targets, institutional (13F) holdings and related news for Entrada Therapeutics Inc are updated in real time on BlackAll Trade.
Entrada Therapeutics Inc trades at $6.75 (-2.17%). Real-time quotes and charts are available on BlackAll Trade.
Entrada Therapeutics Inc has a market cap of about $0.24B.
Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have